# The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias

> **NCT06826157** · NA · ENROLLING_BY_INVITATION · sponsor: **IRCCS San Raffaele** · enrollment: 175 (estimated)

## Conditions studied

- Alzheimer Disease
- Lewy Body Dementia (LBD)
- Mild Alzheimer Disease
- Frontotemporal Dementia (FTD)
- Mild Cognitive Impairment (MCI)
- Healthy Subjects

## Interventions

- **DIAGNOSTIC_TEST:** Electroencephalogram
- **DIAGNOSTIC_TEST:** 3 Tesla MRI
- **GENETIC:** Apolipoprotein E genetic test

## Key facts

- **NCT ID:** NCT06826157
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2021-11-05
- **Primary completion:** 2026-04-15
- **Final completion:** 2027-01-01
- **Target enrollment:** 175 (ESTIMATED)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06826157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06826157, "The Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06826157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*